Milner Therapeutics Institute

A unique joint event which brings together academic and industry scientists from Korea and the UK

High attrition rates in the late development stage, and other challenges in drug discovery, has led to an increased need for developing and applying machine learning and artificial intelligence across the drug discovery pipeline, from target identification to chemical lead selection and prioritisation.

In this online workshop, which consists of 3 morning sessions, we will hear exciting new stories in AI medicine and drug discovery. Each session will conclude with a panel discussion, and there will then be opportunity for networking in our interactive online networking space.

Registration gives you access to the entire event: here

 

Programme:

**Please note all times are GMT**

Monday 22nd February

08.30-08.35 GMT Opening Remarks

08.35-09.05 GMT Hojung Nam (GIST) AI Powered drug discovery and development

09.05-09.35 GMT Namshik Han (University of Cambridge) Data-driven computational analysis and simulation Identified drug repurposing opportunities for COVID-19

09.35-10.05 GMT Hee Jung Koo (Standigm) An explainable drug target identification platform utilising a deep neural net

10.05-10.25 GMT Panel Discussion

10.25-10.30 GMT Closing Remarks

10.30-11.30 GMT Interactive Networking Session

Tuesday 23rd February

08.30-08.35 GMT Opening Remarks

08.35-09.05 GMT Ian Dunham (EMBL-EBI) Opportunities for Machine Learning in identifying and Prioritising Drug Targets

09.05-09.35 GMT Sang Wan Lee (KAIST) In silico experimental design for AI medicine

09.35-10.05 GMT Speakers from GSK (TBC) TBD

10.05-10.25 GMT Panel Discussion

10.25-10.30 GMT Closing Remarks

10.30-11.30 GMT Interactive Networking Session

Wednesday 24th February

08.30-08.35 GMT Opening Remarks

08.35-09.05 GMT Yu Rang Park (Yonsei University) Development of AI-based pharmacovigilance system

09.05-09.35 GMT Mishal Patel (AstraZeneca) TBD

09.35- 10.05 GMT Hyun-Jin Yang (SyntekaBio) Leveraging Genomic Data and AI Drug Development in the ERA of Precision Medicine

10.05-10.25 GMT Panel Discussion

10.25- 10.30 GM T Closing Remarks

10.30-11.30 GMT Interactive Networking Session

 

 

Organisers:

Milner Therapeutics Institute

Tony Kouzarides

Namshik Han

Yonsei University College of Medicine

Jae‐Ho Cheong

Yu Rang Park

 

Funders:

UK Department for Business, Energy and Industrial Strategy

the UK Embassy in Seoul

Ministry of Science and ICT and

National Research Foundation in Korea